CASI Pharmaceuticals, Inc. (CASIF)
0.1025
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
CASI Pharmaceuticals SG&A Expense (Quarterly) : 14.11M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median